Stephen P. Arnerić

9.6k citations

134 papers · 6.7k indexed · h-index 48

Molecular Biology top 1%
Cellular and Molecular Neuroscience top 0.5%
Pharmacology top 0.5%
Physiology top 2%
Organic Chemistry top 2%

Co-authors: Michael Decker Jorge D. Brioni James P. Sullivan Michael Williams Diana L. Donnelly‐Roberts Mark W. Holladay Anthony W. Bannon Murali Gopalakrishnan
Topics: Nicotinic Acetylcholine Receptors Study (71 papers)Cholinesterase and Neurodegenerative Diseases (39 papers)Neuroscience and Neuropharmacology Research (33 papers)
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Pharmacology
Journals: Science Journal of Neuroscience Diabetes
Partner nations: United States United Kingdom Canada

In The Last Decade

Stephen P. Arnerić

133 papers receiving 6.5k citations

Peers

Countries citing papers authored by Stephen P. Arnerić

Since Specialization

Citations

This map shows the geographic impact of Stephen P. Arnerić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Arnerić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Arnerić more than expected).

Fields of papers citing papers by Stephen P. Arnerić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen P. Arnerić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Arnerić. The network helps show where Stephen P. Arnerić may publish in the future.

Co-authorship network of co-authors of Stephen P. Arnerić

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen P. Arnerić. A scholar is included among the top collaborators of Stephen P. Arnerić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen P. Arnerić. Stephen P. Arnerić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain 2011 ·Pain ·Michael E. Hildebrand,Paula L. Smith,Chris Bladen,Cyrus Eduljee,Jennifer Y. Xie,Lina Chen,(unknown),(unknown),Janette Mezeyova,(unknown),Francesco Belardetti,Hassan Pajouhesh,David Parker,Stephen P. Arnerić,(unknown),Frank Porreca,Elizabeth Tringham,Gerald W. Zamponi,Terrance P. Snutch	55
2	A Fluorescence-Based High-Throughput Screening Assay for the Identification of T-Type Calcium Channel Blockers 2009 ·Assay and Drug Development Technologies ·Francesco Belardetti,Elizabeth Tringham,Cyrus Eduljee,Xinpo Jiang,Haiheng Dong,Adam Hendricson,Yoko Shimizu,(unknown),David Parker,Janette Mezeyova,(unknown),Hassan Pajouhesh,Robert Fraser,Stephen P. Arnerić,Terrance P. Snutch	23
3	A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:In VitroandIn VivoCharacterization 2005 ·Journal of Neuroscience ·Raymond S Hurst,Mihály Hajós,M. Raggenbass,Theron M. Wall,Nicole R. Higdon,Judy A. Lawson,(unknown),Mitchell B. Berkenpas,William E. Hoffmann,David W. Piotrowski,Vincent E. Groppi,(unknown),Roch Ogier,Sonia Bertrand,Daniel Bertrand,Stephen P. Arnerić	372
4	Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential 2003 ·Psychopharmacology ·(unknown),Mark Prendergast,Alvin V. Terry,Stephen P. Arnerić,Mark A. Smith,Jerry J. Buccafusco	22
5	Expression of the α4 isoform of the nicotinic acetylcholine receptor in the fetal human cerebral cortex 2001 ·Developmental Brain Research ·Hannsjörg Schröder,Ulrich Schütz,Lothar Burghaus,Jon Lindstrom,Alexander Kuryatov,Lisa M. Monteggia,(unknown),Gerard van Noort,Andrea Wevers,Sonja Nowacki,(unknown),Natasha Moser,Stephen P. Arnerić,Alfred Maelicke	9
6	Neuronal nicotinic receptors : pharmacology and therapeutic opportunities 1999 ·Stephen P. Arnerić,Jorge D. Brioni	169
7	Gain of function mutation of the α7 nicotinic receptor: distinct pharmacology of the human α7V274T variant 1999 ·European Journal of Pharmacology ·Clark A. Briggs,David G. McKenna,Lisa M. Monteggia,Edward Touma,(unknown),Stephen P. Arnerić,Murali Gopalakrishnan,James P. Sullivan	26
8	Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework 1999 ·Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin,(unknown),David Gunn,Suzanne A. Lebold,Edmund Lee,James T. Wasicak,(unknown),Jerome F. Daanen,David S. Garvey,Jeffrey E. Campbell,(unknown),Michael T. Williams,Stephen P. Arnerić	12
9	Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo 1997 ·Pharmacology Biochemistry and Behavior ·Clark A. Briggs,David J. Anderson,Jorge D. Brioni,Jerry J. Buccafusco,Michael Buckley,Jeffrey E. Campbell,Michael Decker,Diana L. Donnelly‐Roberts,Richard L. Elliott,Murali Gopalakrishnan,Mark W. Holladay,Yu‐Hua Hui,William James Jackson,David J.B. Kim,Kennan C. Marsh,Alyssa B. O'Neill,Mark Prendergast,Keith B. Ryther,James P. Sullivan,Stephen P. Arnerić	171
10	Evidence for Nicotinic Receptors Potentially Modulating Nociceptive Transmission at the Level of the Primary Sensory Neuron: Studies with F11 Cells 1997 ·Journal of Neurochemistry ·Pamela S. Puttfarcken,Arlene M. Manelli,Stephen P. Arnerić,Diana L. Donnelly‐Roberts	38
11	ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties 1997 ·Journal of Pharmacology and Experimental Therapeutics ·James P. Sullivan,Diana L. Donnelly‐Roberts,(unknown),David J. Anderson,Murali Gopalakrishnan,(unknown),Marietta Piattoni-Kaplan,Eduardo Molinari,Jeffrey E. Campbell,David G. McKenna,David Gunn,Nan‐Horng Lin,Keith B. Ryther,Yun He,Mark W. Holladay,Susan Wonnacott,Michael T. Williams,Stephen P. Arnerić	70
12	Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor 1995 ·European Journal of Pharmacology Molecular Pharmacology ·Murali Gopalakrishnan,Bruno Buisson,Edward Touma,Tony Giordano,(unknown),(unknown),Diana L. Donnelly‐Roberts,Stephen P. Arnerić,Daniel Bertrand,James P. Sullivan	155
13	ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity 1995 ·Psychopharmacology ·Jorge D. Brioni,David J.B. Kim,Mark S. Brodie,Michael Decker,Stephen P. Arnerić	21
14	Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats 1994 ·International Journal of Developmental Neuroscience ·Lisa M. Monteggia,Stephen P. Arnerić,Thomas P. Giordano	18
15	Age-related changes in brainstem auditory neurotransmitters: Measures of GABA and acetylcholine function 1994 ·Hearing Research ·Ahmad Raza,Joseph C. Milbrandt,Stephen P. Arnerić,Donald M. Caspary	89
16	Effects of lobeline, a nicotinic receptor agonist, on learning and memory 1993 ·Pharmacology Biochemistry and Behavior ·Michael Decker,Mark J. Majchrzak,Stephen P. Arnerić	86
17	Nicotinic receptor agonists facilitate retention of avoidance training: Participation of dopaminergic mechanisms 1993 ·Behavioral and Neural Biology ·Jorge D. Brioni,Stephen P. Arnerić	57
18	Glutamate in the inferior colliculus plays a critical role in audiogenic seizure initiation 1992 ·Epilepsy Research ·Carl L. Faingold,(unknown),(unknown),Marcus E. Randall,Awais Riaz,Cathy A.Boersma Anderson,Stephen P. Arnerić	62
19	Evidence for clonidine presynaptically modulating amino acid release in the rostral ventral medulla: role in hypertension 1990 ·Brain Research ·F. David Tingley,Stephen P. Arnerić	32
20	Does acetylcholine released within the C1 area of the rostral ventrolateral medulla (RVL) tonically maintain arterial pressure 1986 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·Stephen P. Arnerić,R. Giuliano,Paul Ernsberger,(unknown),D.J. Reis	5

About Stephen P. Arnerić

Stephen P. Arnerić is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Behavioral Neuroscience, having authored 134 papers that have together received 6.7k indexed citations. Recurring topics across this work include Nicotinic Acetylcholine Receptors Study (71 papers), Cholinesterase and Neurodegenerative Diseases (39 papers) and Neuroscience and Neuropharmacology Research (33 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.3k citations), Behavioral Neuroscience (351 citations) and Pharmacology (1.4k citations). Stephen P. Arnerić has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Michael Decker, Jorge D. Brioni, James P. Sullivan, Michael Williams, Diana L. Donnelly‐Roberts, Mark W. Holladay, Anthony W. Bannon, Murali Gopalakrishnan, David J. Anderson and Donald J. Reis. Their work appears in journals such as Science, Journal of Neuroscience and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact